Sign Up Today and Learn More About ZeOmega Stock

Invest in or calculate the value of your shares in ZeOmega or other pre-IPO companies through EquityZen's platform.

Get Started

ZeOmega Stock

ZeOmega provides software for integrated care management, enabling health care managers to track individuals and their treatments.

About ZeOmega Stock

Founded

2001

Headquarters

Frisco, TX, US

Notable Investor

Sandbox Industries

ZeOmega, founded in 2001, provides a powerful population health management platform for payers, providers and value-based care organizations. The high-value, strategic solution is designed to integrate workflow, analytics, content, and communication capabilities.

With deep domain expertise and a comprehensive understanding of complex population health challenges, ZeOmega delivers solutions to facilitate collaboration among stakeholders—which in turn enables clients to implement disparate health care management strategies for overall improvement in quality of care, provider performance, individual patient and member satisfaction, and cost savings.

Reliable, responsive and dedicated to meeting customer expectations and project benchmarks, ZeOmega is the right technology partner for health plans, disease management organizations, patient-centered medical homes, medical management organizations, third-party administrators, and other organizations providing medical and care management services.

Investors in ZeOmega

Discover investors in ZeOmega stock and explore their portfolio companies

ZeOmega Management

Leadership team at ZeOmega

Co-Founder and Vice President

Sadananda Rai

Board Member

Phil Yates

Locked Features

Join now and verify your accreditation status to gain access to:

  • ZeOmega current valuation
  • ZeOmega stock price
  • Available deals in ZeOmega and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in ZeOmega stock?

Accredited investors can buy pre-IPO stock in companies like ZeOmega through EquityZen funds. These investments are made available by existing ZeOmega shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ZeOmega stock?

Shareholders can sell their ZeOmega stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."